New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.
UCLA experts say the effort, which includes complying with rules for masking and distancing, will take vigilance on the part of schools, students and families.
A new study published in JAMA Open Network indicates Black women and Latinas as well as less-educated and lower-income women have not been able to obtain 3D mammography as easily as white, well-educated and higher-income women.
Cardiac Rehab Program leaders are reaching out to heart patients to remind them that delaying care is dangerous and that the rehab clinic’s COVID-19 measures keep patients very safe.
UC Davis Health has joined with several of the nation’s top health systems to help launch a NIH-sponsored initiative for an new digital therapeutics toolkit targeting inflammatory bowel disease.
In a new study, UCSF and Stanford researchers have identified a central switch that appears to control when neural progenitor cells stop multiplying and start differentiating into mature neurons.
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
Gastrointestinal stromal tumors (GISTs) are a subtype of cancers known as sarcomas. GIST is the most common type of sarcoma with approximately 5,000 to 6,000 new patient cases annually in the United States. GIST cannot be cured by drugs alone, and targeted therapies are only modestly effective,...
Health Media Contacts
Find the best contact for health-related media inquiries.
